Search research articles
Contact Us
Filters
Showing results (251-260 of 368) with videos related to
Page
of 37
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection
David A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
The International Journal on Drug Policy
|
June 10, 2025
Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs: A five-year retrospective program evaluation
Carly Mallise, Danika Tremain, Maya Lindsay, et al.
Journal of Viral Hepatitis
|
November 25, 2016
A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies
Sofia R Bartlett, Joel O Wertheim, Rowena A Bull, et al.
CMAJ Open
|
December 27, 2016
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
Alison D Marshall, Sahar Saeed, Lisa Barrett, et al.
Antiviral Therapy
|
February 12, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies
Marianne Martinello, Margaret Hellard, David Shaw, et al.
The Lancet. Gastroenterology & Hepatology
|
April 15, 2019
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study
Adam Trickey, Hannah Fraser, Aaron G Lim, et al.
Viruses
|
November 11, 2022
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study
Anna Conway, Phillip Read, Rosie Gilliver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study
Heather Valerio, Maryam Alavi, Matthew Law, et al.
Implementation Science Communications
|
June 18, 2026
Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study)
Meagan Mooney, Charlene Weight, Mia J Biondi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 28, 2022
Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
Jack Stone, Aaron G Lim, Gregory J Dore, et al.
Page
of 37
Search research articles
Search
Showing results (251-260 of 368) with videos related to
Sort By:
Page
of 37
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2016
Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection
David A Sheridan, Behzad Hajarizadeh, Fiona I Fenwick, et al.
The International Journal on Drug Policy
|
June 10, 2025
Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs: A five-year retrospective program evaluation
Carly Mallise, Danika Tremain, Maya Lindsay, et al.
Journal of Viral Hepatitis
|
November 25, 2016
A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies
Sofia R Bartlett, Joel O Wertheim, Rowena A Bull, et al.
CMAJ Open
|
December 27, 2016
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
Alison D Marshall, Sahar Saeed, Lisa Barrett, et al.
Antiviral Therapy
|
February 12, 2016
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies
Marianne Martinello, Margaret Hellard, David Shaw, et al.
The Lancet. Gastroenterology & Hepatology
|
April 15, 2019
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study
Adam Trickey, Hannah Fraser, Aaron G Lim, et al.
Viruses
|
November 11, 2022
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study
Anna Conway, Phillip Read, Rosie Gilliver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study
Heather Valerio, Maryam Alavi, Matthew Law, et al.
Implementation Science Communications
|
June 18, 2026
Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study)
Meagan Mooney, Charlene Weight, Mia J Biondi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 28, 2022
Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
Jack Stone, Aaron G Lim, Gregory J Dore, et al.
Page
of 37